Login
Toggle navigation
Videos
Categories
Trending
HealthBeacon is among four nominees in the Intelligent Automation - Best Use of RPA & Cognitive category, aiming to win the top award.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
The chief executive of HealthBeacon, Jim Joyce
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Weathering Controversy and Forging Ahead in Finance | Michael Rees , co-founder , Blue Owl Capital .
00:10:00
Phunware, Inc CEO Alan Knitowski confirms the formal closure of the acquisition of privately-held Lyte Technology, Inc in an interview with Proactive..|Mike Snavely is Chief Executive Officer & Director of Phunware
00:10:00
BAUER Maschinen GmbH: Our steel heart | Peter Hingott, , BAUER Maschinen GmbH (TS)
00:10:00
Thinking Like the Client|MUNIB HUSSAIN,Finance,Milbank
00:10:00
In Conversation With Mr Nick Collins, Chief Operating Officer, Clarkson Dubai | Andi Case, CEO, Clarkson PLCCKN:LSE
00:10:00
Living a Meaningful Life with EP Wealth Advisors' Co-Founder Brian E. Parker | Brian E. Parker, Co-Founder, EP Wealth Advisors.
00:10:00
Accelerating Impact Founders & Investors|Alex Guerrero,General Partner,Act One Ventures
00:10:00
John Miniotis, President and CEO of AbraSilver, announces the subscription price of C$0.40 per Common Share for Central Puerto SA (NYSE: CEPU).
00:10:00
Slip-sweep technology in DMT 3D wireless seismic | Maik Tiedemann , Chief Executive at DMT Group (TS)
00:10:00
A2A highlights Andres Acebo and features a CEO spotlight on Priscilla Almodovar joining Fannie Mae as CEO.
00:10:00
Vision Lithium Corporate Presentation Highlights
00:10:00
Comprehensive Expertise in ESOP Transactions: Tax, Finance, Banking, and Valuation